Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease

Metal-Score as a Potential Non-Invasive Diagnostic Test for Alzheimer’s Disease

(2013) Rosanna Squitti et al.   Current Alzheimer Research

Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis

(2013) M. Schrag et al.   NEUROBIOLOGY OF DISEASE

Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance

(2013) Itender Singh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease

(2012) George J. Brewer   BIOFACTORS

Apolipoprotein ε4-Allele as a Significant Risk Factor for Conversion from Mild Cognitive Impairment to Alzheimer’s disease: a Meta-analysis of Prospective Studies

(2012) Ma Fei et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study

(2012) Sebastian Palmqvist et al.   PLoS One

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Progression from MCI to AD: Predictive value of CSF Aβ42 is modified by APOE genotype

(2009) Maartje I. Kester et al.   NEUROBIOLOGY OF AGING

Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease

(2009) R. Squitti et al.   NEUROLOGY

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment

(2008) A. S. Fleisher et al.   NEUROLOGY

Therapeutics for Alzheimer’s disease based on the metal hypothesis

(2008) Ashley I. Bush et al.   Neurotherapeutics

APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease

(2007) A. Barabash et al.   NEUROBIOLOGY OF AGING